Market Closed -
Euronext Bruxelles
11:36:31 2024-04-26 am EDT
|
5-day change
|
1st Jan Change
|
23.75
EUR
|
+0.42%
|
|
+1.06%
|
-15.93%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
1,357
|
1,409
|
1,439
|
1,438
|
1,787
|
2,002
|
-
|
-
|
Enterprise Value (EV)
1 |
1,705
|
1,610
|
1,514
|
1,498
|
1,787
|
1,965
|
1,904
|
1,816
|
P/E ratio
|
14.1
x
|
14.2
x
|
7.65
x
|
6.34
x
|
16.2
x
|
15.7
x
|
11.5
x
|
10.1
x
|
Yield
|
-
|
-
|
-
|
2.25%
|
-
|
3.16%
|
3.26%
|
3.37%
|
Capitalization / Revenue
|
0.78
x
|
0.81
x
|
0.69
x
|
0.56
x
|
0.61
x
|
0.69
x
|
0.67
x
|
0.65
x
|
EV / Revenue
|
0.98
x
|
0.93
x
|
0.73
x
|
0.58
x
|
0.61
x
|
0.68
x
|
0.64
x
|
0.59
x
|
EV / EBITDA
|
6.37
x
|
5.12
x
|
4.27
x
|
3.44
x
|
-
|
5.96
x
|
5.06
x
|
4.56
x
|
EV / FCF
|
14.8
x
|
8.81
x
|
-
|
-
|
-
|
11
x
|
12
x
|
11.5
x
|
FCF Yield
|
6.77%
|
11.4%
|
-
|
-
|
-
|
9.06%
|
8.35%
|
8.71%
|
Price to Book
|
1.65
x
|
1.56
x
|
1.27
x
|
1.03
x
|
-
|
1.01
x
|
0.97
x
|
0.93
x
|
Nbr of stocks (in thousands)
|
43,155
|
43,155
|
43,155
|
43,123
|
63,241
|
84,292
|
-
|
-
|
Reference price
2 |
31.45
|
32.65
|
33.35
|
33.35
|
28.25
|
23.75
|
23.75
|
23.75
|
Announcement Date
|
3/26/20
|
3/25/21
|
3/24/22
|
3/23/23
|
4/5/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
1,743
|
1,737
|
2,082
|
2,588
|
2,928
|
2,893
|
2,986
|
3,103
|
EBITDA
1 |
267.7
|
314.6
|
354.2
|
434.8
|
-
|
329.8
|
376.2
|
398.1
|
EBIT
1 |
134.9
|
184
|
223.8
|
300.1
|
120.1
|
128
|
170.6
|
188.5
|
Operating Margin
|
7.74%
|
10.59%
|
10.75%
|
11.6%
|
4.1%
|
4.42%
|
5.71%
|
6.08%
|
Earnings before Tax (EBT)
1 |
116.5
|
-
|
-
|
-
|
116.4
|
124.5
|
176
|
190.4
|
Net income
1 |
96.1
|
99.1
|
-
|
-
|
109.5
|
93.9
|
125.4
|
140
|
Net margin
|
5.51%
|
5.7%
|
-
|
-
|
3.74%
|
3.25%
|
4.2%
|
4.51%
|
EPS
2 |
2.230
|
2.300
|
4.360
|
5.260
|
1.740
|
1.515
|
2.070
|
2.355
|
Free Cash Flow
1 |
115.4
|
182.8
|
-
|
-
|
-
|
178.1
|
159
|
158.2
|
FCF margin
|
6.62%
|
10.52%
|
-
|
-
|
-
|
6.16%
|
5.32%
|
5.1%
|
FCF Conversion (EBITDA)
|
43.11%
|
58.11%
|
-
|
-
|
-
|
54%
|
42.27%
|
39.74%
|
FCF Conversion (Net income)
|
120.08%
|
184.46%
|
-
|
-
|
-
|
189.67%
|
126.79%
|
113%
|
Dividend per Share
2 |
-
|
-
|
-
|
0.7500
|
-
|
0.7500
|
0.7750
|
0.8000
|
Announcement Date
|
3/26/20
|
3/25/21
|
3/24/22
|
3/23/23
|
4/5/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020 S1
|
2020 S2
|
2021 S1
|
2022 S1
|
---|
Net sales
1 |
935
|
802.3
|
1,021
|
1,340
|
EBITDA
1 |
182
|
132.6
|
184.7
|
247.6
|
EBIT
1 |
-
|
-
|
-
|
182.6
|
Operating Margin
|
-
|
-
|
-
|
13.63%
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
Net income
|
-
|
-
|
-
|
-
|
Net margin
|
-
|
-
|
-
|
-
|
EPS
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
Announcement Date
|
8/27/20
|
3/25/21
|
8/27/21
|
8/25/22
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
348
|
201
|
74.8
|
59.5
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
37.2
|
98.1
|
186
|
Leverage (Debt/EBITDA)
|
1.298
x
|
0.6395
x
|
0.2112
x
|
0.1368
x
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
115
|
183
|
-
|
-
|
-
|
178
|
159
|
158
|
ROE (net income / shareholders' equity)
|
12.3%
|
11.5%
|
18.5%
|
17.9%
|
-
|
5.4%
|
6.6%
|
6.9%
|
ROA (Net income/ Total Assets)
|
5.13%
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
1,874
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
2 |
19.10
|
20.90
|
26.20
|
32.50
|
-
|
23.40
|
24.50
|
25.60
|
Cash Flow per Share
2 |
5.100
|
6.550
|
5.760
|
4.630
|
-
|
4.920
|
5.510
|
5.900
|
Capex
1 |
104
|
99.5
|
-
|
-
|
-
|
158
|
157
|
158
|
Capex / Sales
|
5.98%
|
5.73%
|
-
|
-
|
-
|
5.44%
|
5.24%
|
5.08%
|
Announcement Date
|
3/26/20
|
3/25/21
|
3/24/22
|
3/23/23
|
4/5/24
|
-
|
-
|
-
|
Last Close Price
23.75
EUR Average target price
35.33
EUR Spread / Average Target +48.77% Consensus |
1st Jan change
|
Capi.
|
---|
| -15.93% | 2.14B | | -0.19% | 74.89B | | +0.09% | 46.52B | | -4.19% | 30.82B | | +9.85% | 18.19B | | -10.05% | 11.54B | | -8.09% | 9.73B | | +2.79% | 9.4B | | +6.35% | 9.37B | | +3.85% | 8.11B |
Diversified Chemicals
|